Stephen Gunstream Purchases 80,645 Shares of Alpha Teknova, Inc. (NASDAQ:TKNO) Stock

Alpha Teknova, Inc. (NASDAQ:TKNO) CEO Stephen Gunstream bought 80,645 shares of the business’s stock in a transaction on Friday, July 12th. The stock was bought at an average price of $1.24 per share, for a total transaction of $99,999.80. Following the purchase, the chief executive officer now directly owns 243,497 shares of the company’s stock, valued at $301,936.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Alpha Teknova Stock Performance

Shares of NASDAQ:TKNO traded up $0.07 on Tuesday, hitting $1.35. 110,760 shares of the company were exchanged, compared to its average volume of 23,324. The firm has a market capitalization of $55.11 million, a P/E ratio of -1.24 and a beta of 0.34. The company has a current ratio of 5.52, a quick ratio of 3.92 and a debt-to-equity ratio of 0.16. Alpha Teknova, Inc. has a 1-year low of $1.16 and a 1-year high of $4.27. The stock’s 50 day moving average price is $1.61 and its 200 day moving average price is $2.41.

Alpha Teknova (NASDAQ:TKNO) last announced its quarterly earnings data on Monday, May 13th. The company reported ($0.20) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.04. The business had revenue of $9.29 million for the quarter, compared to analyst estimates of $7.80 million. Alpha Teknova had a negative return on equity of 38.24% and a negative net margin of 97.85%. During the same period in the prior year, the company earned ($0.31) earnings per share. Sell-side analysts predict that Alpha Teknova, Inc. will post -0.65 EPS for the current year.

Analyst Ratings Changes

Separately, Stephens reissued an “overweight” rating and issued a $5.00 price target on shares of Alpha Teknova in a report on Wednesday, July 10th.

Institutional Trading of Alpha Teknova

Several large investors have recently made changes to their positions in the business. Conestoga Capital Advisors LLC boosted its stake in shares of Alpha Teknova by 4.1% in the fourth quarter. Conestoga Capital Advisors LLC now owns 247,529 shares of the company’s stock worth $923,000 after buying an additional 9,800 shares during the last quarter. Fielder Capital Group LLC acquired a new stake in Alpha Teknova in the 4th quarter worth about $156,000. State Board of Administration of Florida Retirement System purchased a new position in Alpha Teknova in the 1st quarter valued at $35,000. Redmile Group LLC boosted its position in Alpha Teknova by 6.5% during the first quarter. Redmile Group LLC now owns 171,453 shares of the company’s stock worth $434,000 after acquiring an additional 10,448 shares during the last quarter. Finally, FourWorld Capital Management LLC acquired a new position in shares of Alpha Teknova during the 1st quarter worth approximately $135,000. 13.81% of the stock is owned by hedge funds and other institutional investors.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.